The third path of tubulointerstitial fibrosis: aberrant endothelial secretome

Mark Lipphardt1, Jong W Song2, Kei Matsumoto3

  • 1Renal Research Institute, Departments of Medicine, Pharmacology and Physiology, New York Medical College at Touro University, Valhalla, New York, USA; Department of Nephrology and Rheumatology, Göttingen University Medical Center, Georg August University, Göttingen, Germany.